Cadenza Bio
Healthcare & Life Sciences
Recent Finacing
Seed
Recent Raise
$2.4M
Cadenza Bio, Inc. is a biotech startup focusing on developing novel small molecule compounds to treat Multiple Sclerosis by promoting remyelination through targeting Estrogen Receptor β (ERβ).
Focus Areas
Biotechnology
Multiple Sclerosis Treatment
Remyelination
Non-Clinical Studies
Small Molecule Compounds
Estrogen Receptor β Targeting
Investors
